or
forgot password

    • cancer clinical trials in anniston, AL

    • Surgery in Treating Patients With Prostate Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Prostate Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Regional Medical Center
    Anniston, Alabama 36202
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Regional Medical Center
    Anniston, Alabama 36202
    Esophageal Cancer, Gastric Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Pediatric Care Center of NE Alabama
    Anniston, Alabama 36207
    Atopic Dermatitis
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Northeast Alabama Medical Center
    Anniston, Alabama 36207
    Non-Small Cell Lung Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Regional Medical Center
    Anniston, Alabama 36202
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Regional Medical Center
    Anniston, Alabama 36202
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    S0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast Cancer
    Regional Medical Center
    Anniston, Alabama 36202
    brca1 Mutation Carrier, brca2 Mutation Carrier, Breast Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Docetaxel in Treating Patients With Solid Tumors
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Bladder Cancer, Breast Cancer, Head and Neck Cancer, Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Thoracoscopy in Patients With Stage IIIA Non-Small Cell Lung Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Lung Cancer
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Leukemia
    Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Lymphoma
    Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Anxiety Disorder, Depression, Fatigue, Lung Cancer
    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Lymphoma
    Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Pancreatic Cancer
    Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Colorectal Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Pancreatic Cancer
    Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Lymphoma
    Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Colorectal Cancer, Neoplasm Metastasis
    Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Lung Cancer
    Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Breast Cancer
    Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Colorectal Cancer, Diarrhea, Neutropenia
    PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Malignant Mesothelioma
    Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Head and Neck Cancer
    Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Lung Cancer
    Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Neoplasms, Unknown Primary
    Vinflunine Plus Trastuzumab in HER2 Over-Expressing Metastatic Breast Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Breast Neoplasms, Breast Cancer
    Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Carcinoma, Small Cell
    5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Rectal Cancer, Cancer of the Rectum, Colorectal Cancer
    APF530 or Palonosetron Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
    Anniston Oncology, PC
    Anniston, Alabama 36207
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC
    Northeast Alabama Regional Medical Center
    Anniston, Alabama 36207
    Lung Cancer
    Vitamin D and Breast Cancer Biomarkers in Female Patients
    Regional Medical Center
    Anniston, Alabama 36202
    Breast Cancer
    An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting
    Anniston Oncology/Regional Medical Center
    Anniston, Alabama
    Chemotherapy-Induced Nausea and Vomiting